Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04149158
Other study ID # SNTCT2015
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 2015
Est. completion date September 2017

Study information

Verified date October 2019
Source Fytexia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to evaluate effects of a 16-week supplementation with a polyphenol rich extract, Sinetrol® Xpur, on fat mass accumulation and body weight management improvement.Subjects were overweight or obese and received polyphenol supplement or placebo. A 4-week follow-up as performed to evaluate its effect after supplementation stop.


Recruitment information / eligibility

Status Completed
Enrollment 77
Est. completion date September 2017
Est. primary completion date September 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 25 Years to 55 Years
Eligibility Inclusion Criteria:

- overweight or obese (25 kg.m-2<BMI<42.5kg.m-2)

- healthy

Exclusion Criteria:

- metabolic or chronical disease with treatments (i.e.: diabetes, dyslipidemia, thyroiditis, inflammatory disease, immunological disease, infectious disease, asthma, anxiety and depression)

- food allergy to the ingredients of the product (grapefruit, orange, caffeine, guarana)

- involved in the prior 6 months in a chronic treatment program, eating disorders history, subjected to weight reduction by surgery

- start or quit smoking, high alcohol consumption

- pregnant, breastfeeding, wanting to have a baby,

- menopausal women

Study Design


Related Conditions & MeSH terms

  • Body Weight
  • Change in Total Body Fat Mass Percentage Loss Versus Body Weight

Intervention

Dietary Supplement:
Placebo

Sinetrol® Xpur


Locations

Country Name City State
Spain UCAM Murcia

Sponsors (1)

Lead Sponsor Collaborator
Fytexia

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in total body fat percentage loss versus bodyweight week1; week16; week20